In contrast to CTLA-4, it is viewed that PD-1/PD-L1 pathway acts to restrain T cell responses in the peripheral tissues, such as at the tumor bed where ligand and receptor are both in abundance [1, 34, 46, 47]. This evidence concerns the gene CTLA4 and neoplasm.